I’m guessing that everyone has noticed that in the OTC world investors are reactive not proactive. Currently nothing has changed in the financials or anything else about RXMD to spark interest for typical OTC investors to jump in. When RXMD starts hitting the profitability goals therrebwill be a lot of interest.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.